Who invested in XWPharma?
XWPharma's investors include B Capital.
Who invested in XWPharma
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2020, from 1 source
- Latest round
- Series C, $40MSept 2020
- Investors
- 1
The rounds
- Sept 2020
Founders and team
From XWPharma's own website: 4 on the team.
- Blade TherapeuticsPresident & CEO
- Edward LiuDirector
- James HuangChairman
- Nikki ZhangDirector
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists XWPharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about XWPharma
How much has XWPharma raised?
XWPharma has raised $40M across 1 round since 2020.
When did XWPharma last raise?
XWPharma's most recent round was a Series C of $40M in Sept 2020.
What was XWPharma's biggest round?
Its most recent round, $40M in Sept 2020, is also its largest on record.
Who backed XWPharma first?
XWPharma's first round on record, in Sept 2020, was backed by B Capital.
What stage is XWPharma at?
XWPharma's latest named round is a Series C, in Sept 2020.
Companies like XWPharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.